This report on the biosensors market studies the current as well as future prospects of the market globally. Biosensors are rapidly gaining popularity in the global market due to its wide array of applications in the fields of medical diagnostics, pharmaceuticals, food industry, bio-defense, and industrial processes. The largest application for biosensors since their origin continues to be blood glucose monitors. However, the market is now demonstrating a paradigm shift towards various other applications such as infectious disease monitoring, blood gas analyses, cholesterol testing, pregnancy testing and non-medical applications such as industrial biology, food toxicity detection and military services. Biosensors are now also being positioned for cancer detection and personalized medicine due to its accurate detection of specific biological analyte and reliable imaging of cancer cells. This report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the biosensors market. It also provides information and data analysis of the global biosensors market with respect to market segments based on the type of biosensor technology, applications, end users and their geographic markets.
Obtain the Forthcoming Market Analysis of Biosensors at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1272
Based on technology, the biosensors market is segmented into four major segments: electrochemical, optical, piezoelectric and thermal. Similarly, based on application, the market has been segmented into medical, food toxicity detection, industrial process control, agriculture, environment and others (bio-defense, drug abuse prevention). The biosensors market has also been segmented on the basis of end users which includes point of care testing, home healthcare diagnostics, research laboratories, security and bio-defense, and food industry. The market segments have been extensively analyzed based on their usefulness, efficacy, revenue and geographic coverage. The market size and forecast in terms of USD million for each market segment has been provided for the period from 2012 to 2020. The report also provides the compounded annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.
Geographically, the biosensors market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). The market size and forecast for each of these regions has been provided for the period from 2012 to 2020, along with their respective CAGRs for the forecast period from 2014 to 2020, considering 2013 as the base year. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s five forces analysis and the key players’ market share analysis in 2013 in order to present a thorough analysis of the overall competitive scenario in the global biosensors market.
A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market and thereby establish a foothold. The report also profiles major players of the biosensors market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Abbott Point of Care, Inc., Medtronic, Inc., LifeScan, Inc., F. Hoffmann-La Roche Ltd., AgaMatrix, Inc., Animas Corporation, LifeSensors, Inc., Siemens Healthcare and Nova Biomedical Corporation.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453